Patents by Inventor Glenn Martin

Glenn Martin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11920347
    Abstract: A joist assembly system that is structured for dynamic retrieval of components, dynamic and precise positioning and location of retrieved components, assembly of the components to form a joist, and delivery of the assembled joist. The joist assembly system has a plurality of material handling systems, a plurality of welding systems, and a rigging table system. The material handling systems are structured to load and position the components such as chords and webs onto the rigging table. The rigging table in turn supports the chords or webs. Subsequently, the plurality of welding systems weld the webs to the chords to form the joist.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: March 5, 2024
    Assignee: NUCOR CORPORATION
    Inventors: Jason Alan Freidenberger, Joseph Patrick Cagle, Christopher Ray Couch, Richard Thomas Erickson, Travis Marshall Fuhrman, John Lyman Hale, Matthew Glenn Hire, Christopher William Martin, James E. Ogburn, III, Jonathan Pressley Poston, Peter Michael Puglisi, Phillip Murray Sylvester, Jr., Adam Taylor Watkins
  • Publication number: 20230195905
    Abstract: Methods, systems, apparatuses, devices, and computer program products are described. A virtual machine may receive, from an application associated with a tenant, a request to perform a cryptographic operation for the application at the virtual machine. Based on receiving the request, the virtual machine may determine that the tenant is limited to using a designated set of cryptographic operations in accordance with a cryptographic operation validation policy associated with the tenant. In some examples, the virtual machine may identify a designated version of the cryptographic operation, from the designated set of cryptographic operations, that corresponds to the cryptographic operation indicated by the request in satisfaction of the cryptographic operation validation policy. The virtual machine may execute the designated version of the cryptographic operation and return a result of the execution to the application.
    Type: Application
    Filed: December 20, 2021
    Publication date: June 22, 2023
    Inventors: Prasad Peddada, Glenn Martin Brunette, JR.
  • Publication number: 20220291177
    Abstract: Methods and apparatuses for rapid detection and quantification of analytes are disclosed. The analytes may be opioids such as fentanyl. The method includes the use of an internal standard. The internal standard is introduced into the unknown sample. The method may involve a separation step prior to an electrochemical detection step. In some embodiments, the separation step is omitted. The analyte may be selectively adsorbed onto a surface of an electrode by maintaining a potential on the electrode during which a solution containing the dissolved analyte flows through the electrode. Performing electroanalysis on the analyte-adsorbed electrode detects and quantifies only the adsorbed analyte. In some embodiments, the internal standard is methyl vanillate.
    Type: Application
    Filed: July 23, 2020
    Publication date: September 15, 2022
    Inventors: Glenn Martin SAMMIS, Daniel L. BIZZOTTO, Pouya REZAZADEH-AZAR
  • Publication number: 20220176062
    Abstract: An example of a nitric oxide (NO) generating system includes an NO generating formulation, having: a stable NO donor/adduct; a hydrophilic binder; and an additive. The additive is to control a rate of release of NO from the stable NO donor/adduct after the formulation is exposed to an effective amount of water, water vapor, or blue or ultraviolet (UV) light. This example NO generating system further includes an inhalation device in operative contact with the NO generating formulation.
    Type: Application
    Filed: February 22, 2022
    Publication date: June 9, 2022
    Inventors: Glenn Martin, Aurora L. Fernandez DeCastro, Mark E. Meyerhoff
  • Publication number: 20210178106
    Abstract: A moisture or hydrating liquid activatable solid formulation for nitric oxide (NO) generation includes a nitrite source; a copper (I) or copper (II) catalyst; an NO generation accelerant; and a solid pH buffer. The nitrite source is to generate NO when exposed to an effective amount of moisture or a hydrating liquid. The pH buffer is present in an amount sufficient to render a pH of the moisture or hydrating liquid activatable solid formulation from greater than 4 to about 9.0.
    Type: Application
    Filed: February 23, 2021
    Publication date: June 17, 2021
    Inventors: Glenn Martin, Andrew P. Hunt, Maria Kim, Mark E. Meyerhoff, Malcolm Kahn
  • Publication number: 20210052842
    Abstract: An NO generating system for nasal inhalation includes a nose vent plug, which includes a nitric oxide (NO) impermeable housing and a receptacle. The NO impermeable housing has integrally formed walls that define a partially enclosed interior portion; two nasal protrusions extending from one of the integrally formed walls and in fluid communication with the partially enclosed interior portion; and an air vent defined in another of the integrally formed walls to introduce air flow into the partially enclosed interior portion. The receptacle is in the partially enclosed interior portion, and contains an NO generating formulation or is to receive an NO generating formulation.
    Type: Application
    Filed: April 10, 2020
    Publication date: February 25, 2021
    Inventors: Glenn Martin, Mark E. Meyerhoff, Malcolm Kahn
  • Patent number: 10514354
    Abstract: The present invention relates to analytical testing devices and methods for fabricating electrochemical creatinine biosensors, and in particular using point of care electrochemical biosensors for testing for creatinine in samples. For example, the present invention may be directed to a biosensor having an electrode, a first printed layer formed on the electrode and having a first matrix that includes creatinine amidohydrolase (CNH), creatine amidinohydrolase (CRH), and sarcosine oxidase (SOX), and second printed layer formed over the first printed layer and having a second matrix that includes CRH, SOX, and catalase.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: December 24, 2019
    Assignee: Abbott Point of Care Inc.
    Inventors: Tian-Xian Zhao, Glenn Martin, Kenneth Hardage, Steven R. Breeze, Stephen Snyder
  • Patent number: 10186174
    Abstract: Methods and devices for determining device usability, e.g., for point of care assay devices. In one embodiment, the invention is to a method of determining device usability in a sensing device, including the steps of: providing a device comprising a first electrical pad; a second electrical pad; and a first polymer layer contacting at least a portion of the first and the second electrical pads and a second polymer layer contacting the first polymer layer and not the first and second electrical pads; applying a potential across the first and the second electrical pads; measuring an electrical property associated with the first and the second polymer layers; and determining whether the measured electrical property associated with the first and the second polymer layers has exceeded a threshold level associated with the device usability.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: January 22, 2019
    Assignee: Abbott Point of Care Inc.
    Inventors: Glenn Martin, Tian-Xian Zhao, Stephen L. Snyder
  • Publication number: 20180075782
    Abstract: Methods and devices for determining device usability, e.g., for point of care assay devices. In one embodiment, the invention is to a method of determining device usability in a sensing device, including the steps of: providing a device comprising a first electrical pad; a second electrical pad; and a first polymer layer contacting at least a portion of the first and the second electrical pads and a second polymer layer contacting the first polymer layer and not the first and second electrical pads; applying a potential across the first and the second electrical pads; measuring an electrical property associated with the first and the second polymer layers; and determining whether the measured electrical property associated with the first and the second polymer layers has exceeded a threshold level associated with the device usability.
    Type: Application
    Filed: September 13, 2017
    Publication date: March 15, 2018
    Inventors: Glenn Martin, Tian-Xian Zhao, Stephen L. Snyder
  • Patent number: 9792838
    Abstract: Methods and devices for determining device usability, e.g., for point of care assay devices. In one embodiment, the invention is to a method of determining device usability in a sensing device, including the steps of: providing a device comprising a first electrical pad; a second electrical pad; and a first polymer layer contacting at least a portion of the first and the second electrical pads and a second polymer layer contacting the first polymer layer and not the first and second electrical pads; applying a potential across the first and the second electrical pads; measuring an electrical property associated with the first and the second polymer layers; and determining whether the measured electrical property associated with the first and the second polymer layers has exceeded a threshold level associated with the device usability.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: October 17, 2017
    Assignee: Abbott Point of Care Inc.
    Inventors: Glenn Martin, Tian-Xian Zhao, Stephen Lee Snyder
  • Publication number: 20170100389
    Abstract: Tetrahydroprotoberbine (THPB) compounds and their use in the treatment of neurological, psychiatric and neurodegenerative diseases is provided. The compounds include d-govadine, l-govadine and racemic govadine, as well as d-THPBs of general formula (I). Enantioselective processes for preparing compounds of formula (I), and d- and l-govadine are also provided.
    Type: Application
    Filed: December 21, 2016
    Publication date: April 13, 2017
    Inventors: James Jackson Miller, Anthony George Phillips, Christopher Court Lapish, Glenn Martin Sammis
  • Patent number: 9594046
    Abstract: Methods and devices for determining sensing device usability, e.g., for self-monitoring and point of care devices. In one embodiment, the invention is to a method of determining device usability, comprising the steps of providing a device comprising a first electrical pad; a second electrical pad; and a humidity-responsive polymer layer contacting at least a portion of the first and second electrical pads; applying a potential across the first and second electrical pads; measuring an electrical property associated with the humidity-responsive polymer layer; and determining whether the measured electrical property associated with the humidity-responsive polymer layer has exceeded a humidity threshold level associated with the device usability.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: March 14, 2017
    Assignee: ABBOTT POINT OF CARE INC.
    Inventors: Glenn Martin, Yi Wang, Simon Tonks, Benjamin J. Feldman
  • Patent number: 9562874
    Abstract: This invention relates to mutagenized redox oxidase enzymes used to design enzyme electrodes with improved interference characteristics in the presence of mediator and oxygen in the assay. This recombinant modified enzyme has enhanced capability to transfer electrons to redox mediator instead of its natural electron acceptors such as O2, NAD, NADP, etc., which will improve the assay performance with less interference and higher sensitivity.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: February 7, 2017
    Assignee: Abbott Point of Care Inc.
    Inventors: Glenn Martin, G. Bruce Collier, Dan Wang
  • Publication number: 20170023514
    Abstract: The present invention relates to analytical testing devices and methods for fabricating electrochemical creatinine biosensors, and in particular using point of care electrochemical biosensors for testing for creatinine in samples. For example, the present invention may be directed to a biosensor having an electrode, a first printed layer formed on the electrode and having a first matrix that includes creatinine amidohydrolase (CNH), creatine amidinohydrolase (CRH), and sarcosine oxidase (SOX), and second printed layer formed over the first printed layer and having a second matrix that includes CRH, SOX, and catalase.
    Type: Application
    Filed: October 5, 2016
    Publication date: January 26, 2017
    Inventors: Tian-Xian Zhao, Glenn Martin, Kenneth Hardage, Steven R. Breeze, Stephen Snyder
  • Patent number: 9526721
    Abstract: Tetrahydroprotoberbine (THPB) compounds and their use in the treatment of neurological, psychiatric and neurodegenerative diseases is provided. The compounds include d-govadine, l-govadine and racemic govadine, as well as d-THPBs of general formula (I). Enantioselective processes for preparing compounds of formula (I), and d- and l-govadine are also provided.
    Type: Grant
    Filed: August 2, 2012
    Date of Patent: December 27, 2016
    Inventors: James Jackson Miller, Anthony George Phillips, Christopher Court Lapish, Glenn Martin Sammis
  • Patent number: 9487811
    Abstract: The present invention relates to analytical testing devices and methods for fabricating electrochemical creatinine biosensors, and in particular using point of care electrochemical biosensors for testing for creatinine in samples. For example, the present invention may be directed to a biosensor having an electrode, a first printed layer formed on the electrode and having a first matrix that includes creatinine amidohydrolase (CNH), creatine amidinohydrolase (CRH), and sarcosine oxidase (SOX), and second printed layer formed over the first printed layer and having a second matrix that includes CRH, SOX, and catalase.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: November 8, 2016
    Assignee: Abbott Point of Care Inc.
    Inventors: Tian-Xian Zhao, Glenn Martin, Kenneth Hardage, Steven R. Breeze, Stephen Snyder
  • Publication number: 20160313273
    Abstract: Methods and devices for determining sensing device usability, e.g., for self-monitoring and point of care devices. In one embodiment, the invention is to a method of determining device usability, comprising the steps of providing a device comprising a first electrical pad; a second electrical pad; and a humidity-responsive polymer layer contacting at least a portion of the first and second electrical pads; applying a potential across the first and second electrical pads; measuring an electrical property associated with the humidity-responsive polymer layer; and determining whether the measured electrical property associated with the humidity-responsive polymer layer has exceeded a humidity threshold level associated with the device usability.
    Type: Application
    Filed: July 6, 2016
    Publication date: October 27, 2016
    Inventors: Glenn MARTIN, Yi Wang, Simon Tonks, Benjamin J. Feldman
  • Patent number: 9417201
    Abstract: Methods and devices for determining sensing device usability, e.g., for self-monitoring and point of care devices. In one embodiment, the invention is to a method of determining device usability, comprising the steps of providing a device comprising a first electrical pad; a second electrical pad; and a humidity-responsive polymer layer contacting at least a portion of the first and second electrical pads; applying a potential across the first and second electrical pads; measuring an electrical property associated with the humidity-responsive polymer layer; and determining whether the measured electrical property associated with the humidity-responsive polymer layer has exceeded a humidity threshold level associated with the device usability.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: August 16, 2016
    Assignee: Abbott Point of Care Inc.
    Inventors: Glenn Martin, Yi Wang, Simon Tonks, Benjamin J. Feldman
  • Publication number: 20160054248
    Abstract: Methods and devices for determining sensing device usability, e.g., for self-monitoring and point of care devices. In one embodiment, the invention is to a method of determining device usability, comprising the steps of providing a device comprising a first electrical pad; a second electrical pad; and a humidity-responsive polymer layer contacting at least a portion of the first and second electrical pads; applying a potential across the first and second electrical pads; measuring an electrical property associated with the humidity-responsive polymer layer; and determining whether the measured electrical property associated with the humidity-responsive polymer layer has exceeded a humidity threshold level associated with the device usability.
    Type: Application
    Filed: October 30, 2015
    Publication date: February 25, 2016
    Applicant: Abbott Point of Care Inc.
    Inventors: Glenn Martin, Yi Wang, Simon Tonks, Benjamin J. Feldman
  • Patent number: 9224312
    Abstract: Methods and devices for determining sensing device usability, e.g., for point of care immunoassay devices. In one embodiment, the invention is to a method of determining device usability, comprising the steps of providing a device comprising a first electrical pad; a second electrical pad; and a continuous polymer layer contacting at least a portion of the first and second electrical pads; applying a potential across the first and second electrical pads; measuring an electrical property associated with the continuous polymer layer; and determining whether the measured electrical property associated with the continuous polymer layer has exceeded a threshold level associated with the device usability.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: December 29, 2015
    Assignee: Abbott Point of Care Inc.
    Inventors: Glenn Martin, Tian-Xian Zhao, Steven Breeze, Craig Jeffrey, Stephen Lee Snyder